Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 582 results for "sandoz inc"

Generic-Drug Makers Oppose Teva Bid to Delay Copaxone Rivals

Generic-drug makers including Momenta Pharmaceuticals Inc. In a court filing today, Momenta, Novartis AG's Sandoz and Mylan Inc. said they would suffer "immense harm" if barred from selling generic Copaxone in the U.S. after some of the drug's ... BusinessWeek, 2 days ago
[x]  

2 images for "sandoz inc"

Scottrade, 5 months ago
Drug Discovery and Development, 4 months ago

Sandoz launches generic version of Prevpac

PRINCETON, N.J. Sandoz Inc. has rolled out lansoprazole capsules, amoxicillin capsules and clarithromycin tablets, a generic version of the combination medicine Prevpac from Takeda Pharmaceuticals. The Novartis subsidiary said Thursday that it's ...
 Chain Drug Review2 weeks ago Sandoz launches H. pylori infection therapy in US  Individual.com2 weeks ago

Update-Moody's: M&A among generic drug makers raises risk for investors

Teva Pharmaceutical Industries Ltd, Mylan Inc. , Actavis plc and Sandoz For the full text of this story please click the following link: http://www.moodys.com/page/viewresearchdoc.aspx-docid=PR_295755&WT.mc_id=NLTITLE_YYYYMMDD_PR_295755 ...
 Yahoo! Finance3 weeks ago Moody's: M&A among generic drug makers raises risk for investors  Capital Market2 weeks ago
[x]  

Novartis AG Names New Heads Of Alcon, Inc., Sandoz, Inc. Units

 BioSpace1 week ago Novartis : Names New Alcon, Sandoz Division Heads  4 Traders1 week ago Novartis Names New Alcon, Sandoz Division Heads ...  ADVFN UK1 week ago
[x]  

Global Biosimilar Market Outlook 2018

FEATURED COMPANIES 3 SBio Inc. Bioton Dr.Reddy's Labs (DRL) Hospira Ratiopharm GmbH Sandoz GmbH MORE The global biosimilars market is at a crucial turning point, as ...
 Research and Markets1 month ago Global EPO Biosimilars Market Outlook 2018  Research and Markets1 month ago World Market for Biosimilars to 2017: EPO, G-CSF, HGH, Insulin, Interferon alpha, mAbs, Others  Individual.com13 hours ago Global Biosimilars (Recombinant Non-Glycosylated & Recombinant Glycosylated Proteins & Recombinant Peptides) Market 2013-2018  Individual.com2 days ago
[x]  
Chicago Tribune

Supreme Court Grants Certiorari in Teva Pharmaceuticals v. Sandoz

Earlier today, the Supreme Court granted certiorari in the Teva Pharmaceuticals USA, Inc. v. Sandoz Inc. case (Supreme Court docket number 13-854). The sole issue on appeal is encapsulated by the question presented: QUESTION PRESENTED: ...
 JD Supra2 weeks ago The Supreme Court - April 2, 2014  Lexology5 days ago UPDATE 1-Teva asks U.S. Supreme court to stay ruling in Copaxone case  CNBC1 week ago Teva asks Supreme court to stay ruling in Copaxone case  Chicago Tribune1 week ago
[x]  

Teva asks U.S. justices to stay lower court ruling in Copaxone case

WASHINGTON, April 7 (Reuters) - Teva Pharmaceutical Industries Inc on Monday asked the U.S. Supreme Court to prevent an appeals court ruling from going into effect while the justices consider the company's appeal in a patent fight over top-selling ...
 CNBC1 week ago
[x]  
Scottrade

Atossa appoints SVP of global regulatory affairs and quality assurance

Atossa Genetics, Inc., a developer of breast health products, has appointed Ben Chen to the newly created position of senior vice president, or SVP, of global regulatory affairs and quality assurance. Mr Chen will oversee all facets of Atossa's ...
 Individual.com1 week ago ATOSSA GENETICS : Ben R. Chen Joins Atossa Genetics as Senior Vice President of Global Regulatory Affairs and Quality Assurance  4 Traders2 weeks ago Ben R. Chen Joins Atossa Genetics as Senior Vice President of Global Regulatory Affairs and Quality Assurance  Freshnews.com2 weeks ago
[x]  

Ico Therapeutics, Inc. (ICOTF: OTCQX International) | Immune CEO Announces New Operational Leadership Team

(GLOBE NEWSWIRE) -- Immune Pharmaceuticals Inc. (OTCQX:IMNP) (Nasdaq:IMNP) announced today the addition of two new senior members to its management team. Elliot Goldstein, MD, joins as Chief Medical Officer.Dr. Goldsteinbrings a unique track ...
 Pink Sheets2 weeks ago Immune Pharmaceuticals Inc. (IMNP: OTCQX U.S.) | IMMUNE CEO ANNOUNCES NEW OPERATIONAL LEADERSHIP TEAM Elliott Goldstein, MD, joins as Chief Medical Officer, Eugene Williams joins as Chief Operating Officer  Pink Sheets2 weeks ago Immune CEO Announces New Operational Leadership Team  Reuters2 weeks ago Immune Pharmaceuticals, Inc. CEO Announces New Operational Leadership Team  BioSpace2 weeks ago
[x]  
Citybizlist

Pernix Therapeutics Appoints John Sedor to Its Board of Directors

By a News Reporter-Staff News Editor at Biotech Week -- Pernix Therapeutics Holdings, Inc. (NASDAQ: PTX), a specialty pharmaceutical company, announced the appointment of John Sedor as a non-executive Director and Chairman of the Compensation ...
 HispanicBusiness.com4 weeks ago PERNIX THERAPEUTICS HOLDINGS, INC. FILES (8-K) Disclosing Change in Directors or Principal Officers  TMC Net4 weeks ago PERNIX THERAPEUTICS : Appoints John Sedor to Its Board of Directors  4 Traders1 month ago Patent Issued for Cyclosporin Analogues  4 Traders6 days ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - sandoz inc
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less